Jagsonpal Pharmaceuticals Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Jagsonpal Pharmaceuticals has allotted 56,571 equity shares under ESOP on 18 November 2025. Consequent to the above allotment, the paid-up share capital of the Company has increased from Rs. 13,34,49,398 (constituting of 6,67,24,699 equity shares of Rs. 2/- each) to Rs. 13,35,62,540 (constituting of 6,67,81,270 equity shares of Rs. 2/- each).

Powered by Capital Market - Live News

Net profit of Jagsonpal Pharmaceuticals rose 9.69% to Rs 12.57 crore in the quarter ended September 2025 as against Rs 11.46 crore during the previous quarter ended September 2024. Sales declined 0.29% to Rs 74.47 crore in the quarter ended September 2025 as against Rs 74.69 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Jagsonpal Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 3 November 2025.

Powered by Capital Market - Live News

The appointment was made based on the recommendations of the company?s nomination and remuneration committee and audit committee, and subsequently approved by the board.

Vora is a Commerce graduate and a member of the Institute of Chartered Accountants of India (ICAI). He brings with him over 18 years of experience in finance, taxation, and allied laws, having worked across diverse industries.

Jagsonpal Pharmaceuticals engaged in the business of manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients.

The company?s standalone net profit jumped 38.6% to Rs 10.80 crore on 23.1% rise in revenue from operations to Rs 75.61 crore in Q1 FY26 over Q1 FY25.

Shares of Jagsonpal Pharma shed 0.46% to Rs 214.90 on the BSE.

Powered by Capital Market - Live News